Angiotensin Receptor Blockers Use and the Risk of Lung Cancer: A Meta-Analysis

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System- United Kingdom

doi 10.1177/1470320315607391

Full Text

Abstract

Available in

Date

Authors

Publisher

SAGE Publications

Related search

Risk of Pneumonia Associated With Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: Systematic Review and Meta-Analysis

British Medical Journal
Medicine
2012English

Angiotensin-Receptor Blockade and Risk of Cancer: Meta-Analysis of Randomised Controlled Trials

The Lancet Oncology
Oncology
2010English

Asthma and the Risk of Lung Cancer: A Meta-Analysis

Oncotarget
Oncology
2017English

Correction: Asthma and the Risk of Lung Cancer: A Meta-Analysis

Oncotarget
Oncology
2017English

Angiotensin Receptor Blockers (ARBs)

CMAJ
Medicine
2011English

Coffee Drinking and Risk of Lung Cancer--A Meta-Analysis

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2016English

Angiotensin Receptor Blockers Don't Seem to Increase Risk of MI

BMJ
2005English

Angiotensin Receptor Blockers: Rational Prescription Tailored to the Cardiovascular Risk and Comorbidities

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Aspirin Use and Lung Cancer Risk: A Possible Relationship? Evidence From an Updated Meta-Analysis

PLoS ONE
Multidisciplinary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy